18-minute read · Responsive dark-blue guide
Metabolic Health III · Adipokines · Visceral Fat

Peptides and Metabolic Health III: Fat Metabolism, Adipokines, and Visceral Fat

Fat tissue is an endocrine organ. This guide explains adiponectin, leptin, resistin, visfatin, visceral fat, the GH axis, BPC‑157 inflammation context, metabolic markers, myths, and a mobile-ready framework.

AdipokinesVisceral fatGH / IGF‑1BPC‑157
Medical disclaimer: This article is educational and does not diagnose or treat obesity, diabetes, insulin resistance, dyslipidemia, fatty liver, sleep apnea, hormonal disease, or cardiovascular disease. Metabolic disease, medication use, pregnancy, eating disorders, endocrine conditions, and glucose-lowering or weight-loss medications require clinician guidance.

Fat Tissue Is an Endocrine Organ

Adipose tissue is not just a passive calorie warehouse. It secretes hundreds of biologically active molecules that affect the whole body.

Adipokines influence insulin sensitivity, inflammation, appetite, vascular tone, liver metabolism, and cardiometabolic risk. To improve metabolic health, the goal is not only “lose weight,” but improve fat-tissue function and reduce visceral-fat burden.

The practical rule: track waist, body composition, inflammation, and glucose markers — not just scale weight.

Subcutaneous, Visceral, and Brown Fat

Subcutaneous fat

More visible, often less harmful

Subcutaneous fat is often more aesthetic than metabolic. It still matters, but visceral fat is more strongly linked to cardiometabolic risk.

Visceral fat

Inflammatory endocrine organ

Visceral fat surrounds organs and drains into portal circulation, sending inflammatory signals directly toward the liver.

Brown fat

Thermogenic tissue

Brown adipose tissue is involved in heat production. Cold, aerobic exercise, and fasting-style energy signaling are better-established supports.

Peptides and Metabolic Health III: Fat Metabolism, Adipokines, and Visceral Fat — image 1
Educational visual summary for Peptides and Metabolic Health III: Fat Metabolism, Adipokines, and Visceral Fat.
Peptide University banner: peptide learning resources and educational programsSponsored / AffiliatePeptide University · Peptide learning resources and educational programs

Four Key Adipokines

Adiponectin

The “good” adipokine

Supports insulin sensitivity through AMPK context, lowers inflammatory tone, and tends to decrease as visceral fat rises.

  • Fasting-style energy signaling may support it.
  • Aerobic exercise supports AMPK context.
  • Higher adiponectin is generally favorable.
Leptin

Satiety signal with resistance risk

Leptin signals fullness to the brain. In obesity, leptin may be high while the brain becomes resistant to the signal.

  • Sleep loss can worsen leptin resistance.
  • Stress management matters.
  • N3 sleep is metabolically relevant.
Resistin

Inflammation-associated adipokine

Resistin is linked to macrophage activity, insulin resistance, hs‑CRP, and cardiovascular-risk context.

  • Lower visceral fat helps.
  • Aerobic work helps inflammatory tone.
  • BPC‑157 is discussed indirectly.
Visfatin

Insulin-mimetic context

Visfatin has insulin-like properties in some contexts, but its role in obesity and cancer biology is still debated.

  • Evidence remains mixed.
  • GH-axis effects are indirect.
  • Do not overinterpret it as “good.”

GH Axis and Fat Metabolism

Growth hormone is a lipolytic signal. It can activate hormone-sensitive lipase and support breakdown of triglycerides into free fatty acids. But this only makes sense in a larger metabolic context: insulin, calorie balance, training, sleep, and monitoring.

1
Low-insulin context: GH-axis tools are discussed more rationally when insulin is low rather than after late eating.
2
GH → HSL: hormone-sensitive lipase supports triglyceride breakdown and fatty-acid release.
3
IGF‑1 response: can support anabolic context and lean-mass preservation.
4
Visceral-fat reduction: can improve adiponectin/resistin balance and lower inflammatory tone.
5
Monitoring: IGF‑1, estradiol when relevant, glucose markers, hs‑CRP, waist, and body composition.
GH-axis tools require clinician context. They are not weight-loss shortcuts and are not appropriate for everyone.

BPC‑157 and Metabolic Inflammation

Visceral fat in obesity behaves like chronically inflamed tissue. M1-like macrophage activity can increase TNF‑α, IL‑6, MCP‑1, resistin, and systemic inflammatory tone.

BPC‑157 is discussed around lower inflammatory signaling and possible macrophage phenotype shift. This does not mean it burns fat directly. It is better framed as a potential inflammation-environment support tool.

BPC‑157 context: lower inflammatory friction may make fasting, aerobic training, strength training, sleep repair, and nutrition work better — but it does not replace them.
Peptides and Metabolic Health III: Fat Metabolism, Adipokines, and Visceral Fat — image 2
Educational visual summary for Peptides and Metabolic Health III: Fat Metabolism, Adipokines, and Visceral Fat.
Ulta Lab Tests banner: track health markers with lab testing for hormones inflammation and wellnessSponsored / AffiliateUlta Lab Tests · Lab testing for hormones, inflammation, and wellness

Final Metabolic Framework

Foundation

Cannot be bypassed

  • Appropriate fasting-style schedule when safe.
  • Zone 2 aerobic work, 150+ min/week.
  • Strength training 3–4 times weekly.
  • 7–8 hours of sleep with deep sleep.
  • Stress management.
Adjuncts

Only on top

  • GH-axis discussions only with monitoring.
  • Sleep support: glycine/magnesium context.
  • BPC‑157 inflammation context.
  • Epitalon circadian context.
  • Omega‑3, berberine, glycine with interaction awareness.
Reality check

What matters most

  • Insulin context.
  • Calorie and protein structure.
  • Training consistency.
  • Waist change.
  • Inflammation and glucose markers.

Markers of Progress

MarkerWhy it mattersPractical use
Waist circumferencePractical proxy for visceral-fat burdenTrack monthly
Body compositionSeparates fat loss from muscle gainInBody, DEXA, or comparable method
hs‑CRPSystemic inflammatory toneUseful cardiometabolic context
HOMA‑IRInsulin-resistance estimateFasting glucose + insulin
HbA1cLonger-term glucose exposureTrack metabolic trend
TriglyceridesLiver/insulin-resistance contextPart of lipid panel

Two Common Myths

Myth: GH secretagogues will burn fat without nutrition changes.

Fact: GH-axis support cannot overcome high insulin, calorie excess, poor sleep, or lack of training. It is not a substitute for the foundation.

Myth: If the scale does not move, nothing is working.

Fact: Recomposition can reduce fat and increase lean mass simultaneously. Waist, body composition, and metabolic markers are more informative than scale weight alone.

Frequently Asked Questions

Does BPC‑157 burn fat?

No. It is discussed around inflammation context, not direct fat burning.

Are GH secretagogues weight-loss drugs?

No. They are GH-axis tools requiring medical context and monitoring. They do not replace nutrition, exercise, or sleep.

What is the most practical visceral-fat marker?

Waist circumference is simple and useful. Body composition testing adds more detail.

Why does sleep matter for fat metabolism?

Sleep affects leptin sensitivity, cortisol, appetite regulation, and the natural GH pulse.

Can berberine be used with diabetes medications?

Only with clinician guidance, because glucose-lowering effects and medication interactions matter.

Key Takeaways

  • Visceral fat is an inflammatory endocrine organ.
  • Adiponectin is generally favorable; resistin and leptin resistance signal dysfunction.
  • GH-axis support is rational only in the right metabolic and low-insulin context.
  • BPC‑157 is discussed as inflammation-environment support, not fat burning.
  • Nutrition, aerobic training, strength training, sleep, and stress management come first.
  • Track waist, body composition, hs‑CRP, glucose markers, and lipids — not just weight.
  • The page is mobile-responsive: grids collapse, sticky TOC becomes normal, and tables scroll horizontally on small screens.
Next article #081Peptides and Regenerative Medicine: Stem Cells, Growth Factors, Senolytics, and the Future